These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26313861)

  • 41. [Kawasaki disease in Mexican children].
    Vizcaíno-Alarcón A; Arévalo-Salas A; Rodríguez-López AM; Sadowinski-Pine S
    Bol Med Hosp Infant Mex; 1991 Jun; 48(6):398-408. PubMed ID: 1910554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity.
    Martínez-Martínez E; López-Ándres N; Jurado-López R; Rousseau E; Bartolomé MV; Fernández-Celis A; Rossignol P; Islas F; Antequera A; Prieto S; Luaces M; Cachofeiro V
    Hypertension; 2015 Nov; 66(5):961-9. PubMed ID: 26351031
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in causes of sudden deaths by decade in patients with coronary arterial lesions due to Kawasaki disease.
    Tsuda E; Arakaki Y; Shimizu T; Sakaguchi H; Yoshimura S; Yazaki S; Echigo S
    Cardiol Young; 2005 Oct; 15(5):481-8. PubMed ID: 16164786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute pericardial effusion representing the TNF-α-mediated severe inflammation but not the coronary artery outcome of Kawasaki disease.
    Okada S; Hasegawa S; Suzuki Y; Matsubara T; Shimomura M; Okuda M; Ichiyama T; Ohga S
    Scand J Rheumatol; 2015 May; 44(3):247-52. PubMed ID: 25351965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of Galectin-3 as a Novel Biomarker for Chagas Cardiomyopathy.
    Noya-Rabelo MM; Larocca TF; Macêdo CT; Torreão JA; Souza BS; Vasconcelos JF; Souza LE; Silva AM; Ribeiro Dos Santos R; Correia LC; Soares MB
    Cardiology; 2017; 136(1):33-39. PubMed ID: 27548475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice.
    Vergaro G; Prud'homme M; Fazal L; Merval R; Passino C; Emdin M; Samuel JL; Cohen Solal A; Delcayre C
    Hypertension; 2016 Mar; 67(3):606-12. PubMed ID: 26781273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The physiological significance of coronary aneurysms in Kawasaki disease.
    Murakami T; Tanaka N
    EuroIntervention; 2011 Dec; 7(8):944-7. PubMed ID: 22157479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive evaluation of a patient with Kawasaki disease and giant coronary aneurysms with cardiac magnetic resonance.
    Prsa M; Hussain T; McCrindle BW; Grosse-Wortmann L
    Congenit Heart Dis; 2014; 9(6):E195-8. PubMed ID: 23948020
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HLA-E gene polymorphism associated with susceptibility to Kawasaki disease and formation of coronary artery aneurysms.
    Lin YJ; Wan L; Wu JY; Sheu JJ; Lin CW; Lan YC; Lai CH; Hung CH; Tsai Y; Tsai CH; Lin TH; Lin JG; Hsueh KC; Huang YM; Chang JS; Tsai FJ
    Arthritis Rheum; 2009 Feb; 60(2):604-10. PubMed ID: 19180512
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Galectin-3 in cardiac muscle and circulation of dogs with degenerative mitral valve disease.
    Sakarin S; Rungsipipat A; Surachetpong SD
    J Vet Cardiol; 2016 Mar; 18(1):34-46. PubMed ID: 26786977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longterm outcomes in patients with giant aneurysms secondary to Kawasaki disease.
    Levy DM; Silverman ED; Massicotte MP; McCrindle BW; Yeung RS
    J Rheumatol; 2005 May; 32(5):928-34. PubMed ID: 15868632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Giant coronary aneurysms in a young adult patient with Kawasaki disease.
    Canino-Rodríguez A; Cox RA
    P R Health Sci J; 2008 Dec; 27(4):382-6. PubMed ID: 19069372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].
    Peng Q; Zhou TF; Chen CH; Hua YM; Liu HM; Hong H; Zhang LY; Wu Q
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):676-80. PubMed ID: 16191301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease.
    Cheung YF; Ho MH; Tam SC; Yung TC
    Heart; 2004 Nov; 90(11):1281-5. PubMed ID: 15486121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombocytopenia in Kawasaki disease: a risk factor for the development of coronary artery aneurysms.
    Nofech-Mozes Y; Garty BZ
    Pediatr Hematol Oncol; 2003 Dec; 20(8):597-601. PubMed ID: 14578029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coronary artery aneurysms in Kawasaki disease: the Puerto Rican experience.
    Villavicencio R; Sánchez-Rosetti J
    P R Health Sci J; 1987 Apr; 6(1):7-12. PubMed ID: 3615799
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term cardiovascular inflammation and fibrosis in a murine model of vasculitis induced by
    Lombardi Pereira AP; Aubuchon E; Moreira DP; Lane M; Carvalho TT; Mesquita TRR; Lee Y; Crother TR; Porritt RA; Verri WA; Noval Rivas M; Arditi M
    Front Immunol; 2024; 15():1411979. PubMed ID: 38989288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kawasaki disease: a review of pathologic features of stage IV disease and two cases of sudden death among asymptotic young adults.
    Rozin L; Koehler SA; Shakir A; Ladham S; Wecht CH
    Am J Forensic Med Pathol; 2003 Mar; 24(1):45-50. PubMed ID: 12604998
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Galectin-3 as a candidate upstream biomarker for quantifying risks of myocardial ageing.
    Keng BMH; Gao F; Ewe SH; Tan RS; Teo LLY; Xie BQ; Koh WP; Koh AS
    ESC Heart Fail; 2019 Oct; 6(5):1068-1076. PubMed ID: 31392851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Usefulness of Calcium Scoring as a Screening Examination in Patients With a History of Kawasaki Disease.
    Kahn AM; Budoff MJ; Daniels LB; Oyamada J; Gordon JB; Burns JC
    Am J Cardiol; 2017 Apr; 119(7):967-971. PubMed ID: 28193446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.